American Journal of Ophthalmology
Volume 146, Issue 5 , Pages 700-706.e1 , November 2008

Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion

  • Lars-Olof Hattenbach

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
    • Augenklinik des Klinikums Ludwigshafen, Ludwigshafen am Rhein, Germany
    • Corresponding Author InformationInquiries to Lars-Olof Hattenbach, Augenklinik des Klinikums Ludwigshafen, Bremserstr 79, 67063 Ludwigshafen am Rhein, Germany
    • ,
  • Claudia Kuhli-Hattenbach

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
    • ,
  • Inge Scharrer

      Affiliations

    • Angiologie, Klinikum der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
    • ,
  • Holger Baatz

      Affiliations

    • Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany

,Accepted 12 June 2008.

References 

  1. Hölschermann H, Krombach C, Jung A, Jacobi F, Tillmanns H, Weinand F. Treatment of acute central retinal artery occlusion with the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban. Thromb Haemost. 2005;94:684–686
  2. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol. 1999;128:733–738
  3. Mueller AJ, Neubauer AS, Schaller U, Kampik A European Assessment Group for Lysis in the Eye. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol. 2003;121:1377–1381
  4. Reynard M, Hanscom TA. Neodymium:yttrium-aluminum-garnet laser arteriotomy with embolectomy for central retinal artery occlusion. Am J Ophthalmol. 2004;137:196–198
  5. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Fonollosa A, Corcostegui B. Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol. 2006;90:1252–1255
  6. Vine AK, Maguire PT, Martonyi C, Kincaid MC. Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi. Am J Ophthalmol. 1988;105:266–270
  7. Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol. 1992;113:429–434
  8. Schumacher M, Schmidt D, Wakhloo AK. Intraarterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology. 1993;35:600–605
  9. Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology. 1999;106:768–773
  10. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol. 2000;84:914–916
  11. Schmidt DP, Schulte-Mönting J, Schumacher M. Prognosis of central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment. Am J Neuroradiol. 2002;23:1301–1307
  12. Butz B, Strotzer M, Manke C, Roider J, Link J, Lenhart M. Selective intraarterial fibrinolysis of acute central retinal artery occlusion. Acta Radiol. 2003;44:680–684
  13. Arnold M, Koerner U, Remonda L, et al. Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatr. 2005;76:196–199
  14. Feltgen N, Neubauer A, Jurklies B, et al. EAGLE-Study Group Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications (EAGLE Study Report No. 1). Graefes Arch Clin Exp Ophthalmol. 2006;244:950–956
  15. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol. 2002;120:1234–1236
  16. von Mach MA, Güz A, Wiechelt J, Pfeiffer N, Weilemann LS. Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion (A case study [in German]). Dtsch Med Wochenschr. 2005;130:1002–1006
  17. Bertram B, Wolf S, Fisches H, et al. Thrombolytic treatment of retinal arterial occlusions with plasminogen activator [in German]. Klin Monatsbl Augenheilkd. 1991;198:295–300
  18. Sloan M, Gore JM. Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. Am J Cardiol. 1992;69:A21–A38
  19. Anderson JL, Karagounis L, Allan A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol. 1991;68:166–170
  20. Hayreh SS, Zimmermann MB, Kimura A, Sanon A. Central retinal artery occlusion (Retinal survival time). Exp Eye Res. 2004;78:723–736
  21. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol. 1980;64:913–917
  22. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995;120:776–783
  23. Ramakrishna G, Malouf JF, Younge BR, Connolly HM, Miller FA. Calcific retinal embolism as an indicator of severe unrecognised cardiovascular disease. Heart. 2005;91:1154–1157
  24. Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007;27:215–230
  25. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922–928
  26. Hacke W, Kaste M, Fieschi C, et al. ECASS Study Group Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke (The European Cooperative Acute Stroke Study Group (ECASS)). JAMA. 1995;274:1017–1025
  27. Suri MF, Nasar A, Hussein HM, Divani AA, Qureshi AI. Intra-arterial thrombolysis for central retinal artery occlusion in the United States: Nationwide In-patient Survey 2001–2003. J Neuroimaging. 2007;17:339–343
  28. Menon V, Harrington RA, Hochman JS, et al. Thrombolysis and adjunctive therapy in acute myocardial infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:S549–S575
  29. Brott TG, Haley EC, Levy DE. Urgent therapy for stroke (I. Pilot study of tissue plasminogen activator administered within 90 minutes). Stroke. 1992;23:632–640
  30. Haley EC, Levy DE, Brott TG. Urgent therapy for stroke (II. Pilot study of tissue plasminogen activator administered 91—180 minutes from onset). Stroke. 1992;23:641–645
  31. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682
  32. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615–1622
  33. Hattenbach LO, Steinkamp GWK, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica. 1998;212:394–398
  34. Biousse V, Trobe JD. Transient monocular visual loss. Am J Ophthalmol. 2005;140:717–721
  35. Tissue plasminogen activator for acute ischemic stroke (The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group). N Engl J Med. 1995;333:1581–1587
  36. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year (National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group). N Engl J Med. 1999;340:1781–1787
  37. The TOAST investigators. Low molecular weight heparinoid, Org 10172 (danaparoid), and outcome after acute ischemic stroke. JAMA. 1998;279:1265–1272

 See accompanying Editorial on page 631.

PII: S0002-9394(08)00482-0

doi: 10.1016/j.ajo.2008.06.016

American Journal of Ophthalmology
Volume 146, Issue 5 , Pages 700-706.e1 , November 2008

Article Tools

* Image Usage & Resolution